Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FANKT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count packages). The contract, valued at $4,311.35, carries a firm fixed-price arrangement with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in open federal procurement markets while leveraging its small business status.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. Xtandi, an oncology medication used in cancer treatment, represents one of many specialized pharmaceutical products within the vendor's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to Department of Defense healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a demonstrated track record of fulfilling diverse medical product requirements across military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FANKT?
SPE2DB25FANKT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FANKT worth?
The government has obligated $4,311 on SPE2DB25FANKT.
Is contract SPE2DB25FANKT an order under another contract?
Yes. SPE2DB25FANKT is a delivery order under SPE2DB24D9227, an indefinite delivery contract.
Was contract SPE2DB25FANKT competed?
The extent of competition for SPE2DB25FANKT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award